论文信息 - Drotrecogin alfa (activated) in patients with severe sepsis and a high risk of death - 字舞流文

Drotrecogin alfa (activated) in patients with severe sepsis and a high risk of death

M. Meade | N. Adhikari | J. Friedrich

[1] Mark D. Williams,et al. Drotrecogin alfa (activated): current evidence supports treatment for severe sepsis patients with a high risk of death , 2006, Critical care.

[2] M. Meade,et al. Drotrecogin alfa (activated): down and not out, but not really in either , 2006, Critical care.

[3] M. Meade,et al. Drotrecogin alfa (activated): does current evidence support treatment for any patients with severe sepsis? , 2006, Critical care.

[4] R. Rossaint,et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. , 2005, The New England journal of medicine.

[5] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[6] J Ean,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. , 2001, The New England journal of medicine.

[7] Jay Steingrub,et al. Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. , 2005 .